Abdul Basit, PhD
Abdul Basit holds the position of Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research is translational in nature and spans drug delivery, 3D printing and digital health. He has founded two spin-out companies from UCL (FabRx and Intract Pharma), and his group has invented a number of drug delivery technologies that have led to new drug products that have reached the market.
To date, more than a million patients have benefited from inventions created and developed by his research group. Abdul and his group have received awards from the AAPS (Young Investigator Award in Pharmaceutics and Pharmaceutical Technology), GlaxoSmithKline (Innovative Science Award), AstraZeneca (Pharmaceutical Science Award) and the Academy of Pharmaceutical Sciences (APS Science Award). Abdul was listed amongst the World’s Most Highly Influential Researchers by the Web of Science in 2019 and 2020.